Numerof at BIO 2018: Strategies for Selling Value
Room 210A, Level 2
As providers continue to consolidate and adopt practices that make them look increasingly like payers, decision-making about products and services is moving away from clinicians and involving more people. In this environment, manufacturers must rethink their approach to the market and how they use data to demonstrate value in the eyes of stakeholders.
Join Numerof Vice President Kim White for a discussion on Strategies for Selling Value in a Dynamic Environment on June 4th. Kim and fellow experts from Amgen, Ferring Pharmaceuticals, and Sunovion will provide insight into the strategies they are using to meet growing demands for a data-based value narrative.
- Dr. Cathy Critchlow, Vice President Observational Research, Amgen, Inc.
- Michael Adatto, Assistant Vice President, Market Access & Head, Pediatric Endocrinology Franchise, Ferring Pharmaceuticals
- Matt Portch, Vice President, Managed Markets, Sunovion Pharmaceuticals
See the conference website for more details. Also, don’t miss Numerof’s other session at BIO 2018, An Investor’s Perspective on Value of New Biotherapeutics.